Skip to main content

Table 3 Comparison of HBV DNA virological response rates between the dyslipidemia and normolipidemic groups at different treatment times (number of subjects, %)

From: Effects of dyslipidemia on E antigen seroconversion of patients with chronic hepatitis B treated by nucleoside (acid) analogs

Groups

Number of Subjects

HBV DNA Virological Response Rate

1st year

2nd year

3rd year

4th year

5th year

Dyslipidemia Group

68

43 (63.2)

47 (69.1)

52 (76.5)

57 (83.8)

61 (89.7)

Normolipidemic Group

111

77 (69.4)

83 (74.8)

93 (83.3)

103 (92.8)

106 (95.5)

Test value

 

0.718

0.679

1.466

3.575

1.429

Р

 

0.397

0.410

0.226

0.059

0.232